Jatin Shah

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics, Inc., 85 Wells Avenue, Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Jatin Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jatin Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, Chief Medical Officer Common Stock 129K $106K $0.82 Feb 17, 2022 Direct

Insider Reports Filed by Jatin Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Feb 17, 2022 1 -$15.8K 4 Feb 22, 2022 EVP, Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Feb 7, 2022 1 -$16.8K 4 Feb 9, 2022 EVP, Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Jul 12, 2021 1 -$6.47K 4 Jul 13, 2021 EVP, Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. May 7, 2021 1 $200K 4 May 11, 2021 EVP, Chief Medical Officer